TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Peripheral IV Site Monitoring

No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: SUPPLY CHAIN COORDINATION LIMITED: "Peripheral IV Site Monitoring". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthoritySUPPLY CHAIN COORDINATION LIMITEDScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: SUPPLY CHAIN COORDINATION LIMITED
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for SUPPLY CHAIN COORDINATION LIMITED. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
9.9Bids / Report
4.2% of reports have one bid
Supplier ConcentrationHigh Concentration
Ingenion Medical LimitedTop vendor: 100% of attributable value
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 69 active published awards; 24 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
Supplier NameHistoric AwardsAttributable GBP Value
Ingenion Medical Limited1 win£4,200,000
Procedure terms
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published5 Feb 2026, 16:21 GMT
Last source update5 Feb 2026, 16:21 GMT
Recurring procurementNot published
ClassificationNot published
Delivery areaLocation not published
OCIDocds-h6vhtk-0553a4
What is being bought
This market exercise was for the provision of a solution to advise the detection of IV infiltrations and extravasations early that includes the following: • Monitoring equipment and Consumables NHS Supply Chain have a mandate from the Department of Health and Social Care (DHSC) to drive the availability of innovative products to the NHS. NHS Supply Chain believe the product sourced by this contract (which is not covered by any of its current Framework Agreements) falls within this remit as a “disruptive” innovative product and has been identified to provide enhanced patient benefits specifically; Patient - improving patient safety Prevention of Never Event - which can lead to skin necrosis, Amputation, Nerve Damage for our most vulnerable patients, Neonates, paediatrics, sedated patients, critically ill and patients with cognitive deficits, along with Patients receiving Vesicant medications. NHS Supply Chain will enter into Framework Agreement (FAG) with an identified supplier of these products/services (alongside the existing framework Infusion Pumps Administration) following the publication of a Transparency notice Published 25 July 2025 [ https://www.find-tender.service.gov.uk/Notice/043122-2025] and no other suppliers were identified. Therefore confirmining 1 available supplier to be awarded using procedure Direct Award as defined in the Procurement Act 2023. The Term of this Framework Agreement is anticipated to be 12 months, with the option to extend to a maximum term of 48 months. As part of its strategy, NHS Supply Chain anticipates engaging with suppliers of these products/services with a view to ultimately include this solution within the scope of the Framework for Infusion Pumps Administration Sets and Associated products which is due to renewal on 30th September 2026 The Framework Agreement will be between NHS Supply Chain and the Supplier, however 1) NHSSC, 2) any NHS Trust; 3) any other NHS entity; 4) any government department, agency or other statutory body and/or 5) any private sector entity active in the UK healthcare sector will be able to enter into a direct contract with the Supplier for any of the supplies and/or services under the Framework. Electronic ordering will be used, and electronic invoicing will be accepted, and electronic payment will be used. For the avoidance of doubt and notwithstanding the estimate indicated, NHSSC does not guarantee any level of purchase through the framework and advises applicants that the framework shall be established on a non-exclusive basis.
What changed
From the official release history
  1. Official notice release published
    5 Feb 2026, 16:21 GMT
  2. Official notice release published
    16 Oct 2025, 15:05 BST
  3. Official notice release published
    22 Sept 2025, 11:50 BST
  4. tender value changed
    25 Jul 2025, 12:56 BST
  5. Status changed to complete
    25 Jul 2025, 12:56 BST
  6. Official notice release published
    25 Jul 2025, 12:56 BST
  7. Published value updated to £2,000,000
    25 Jun 2025, 16:11 BST
  8. Status changed to planning
    25 Jun 2025, 16:11 BST
  9. Official notice release published
    25 Jun 2025, 16:11 BST
  10. Buyer information updated
    25 Jun 2025, 16:11 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    complete
    Published valueNot published
    The source published no individual title or description for this lot.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    5 Feb 2026, 16:21 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 12 Jan 2026, 00:00 GMT · £8,000,000
Commercial outcome and competition
Awards
Healthcare 21 UK Limited
Not published · Not published · active
Contracts
Peripheral IV Site Monitoring Device
£8,000,000 · signed 12 Jan 2026, 00:00 GMT · active
Contract period: 26 Jan 2026, 00:00 GMT30 Sept 2026, 23:59 BST
Bid statisticsNo aggregate bid statistics published
Buyer and organisations in this procedure

SUPPLY CHAIN COORDINATION LIMITED

Contracting authority GB-PPON-PLLH-1887-BMRL
View buyer profile
  • SUPPLY CHAIN COORDINATION LIMITED
    buyer

    GB-PPON: PLLH-1887-BMRL
    Wellington House, 133-155 Waterloo Road, London, UKI45, SE1 8UG, GB
  • Healthcare 21 (UK) Limited
    supplier

    GB-COH: 05020682 · GB-PPON: PBGH-8572-LNQT
    Unit B1-B2 Bond Close, Basingstoke, UKJ37, RG24 8PZ, GB
Documents (1)
Official links; attachments are not copied
  • Not published

    tender
    conflictOfInterest
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationaleSingle supplier - technical reasons Traditional methods rely on periodic clinician assessments, which can miss early signs of infiltration or extravasation, leading to serious complications such as skin necrosis, nerve damage, or medication dosing errors. The ivWatch Patient Monitoring System provides continuous, non-invasive monitoring using optical sensor technology and proprietary algorithms to detect infiltrations at their earliest stages, often before visible signs are present. iv.Watch technology has demonstrated exceptional clinical value in preventing infiltration and extravasation injuries associated with peripheral intravenous (PIV) therapy. This innovation enhances patient safety, reduces liability, and complements clinician assessments, addressing the limitations of periodic monitoring. Research has been carried out on the benefits of the iv Watch technology and can be found in the British Journal of Nursing: British Journal of Nursing - Addressing and mitigating the high costs of extravasation and infiltration to patients and healthcare organisations Due to the absence of competition for technical reasons and that the Manufacturer is only just entering the UK market, only this supplier/distributor can supply the goods required. Procurement Act 2023, Section 41, Schedule 5, Section 6 "There are no reasonable alternatives to those goods, services or works"